Breaking News

Arrowhead Pharmaceuticals Inc (HDP1)

	Symbol	Exchange	Currency
	ARWR	NASDAQ	USD	Real-time
	HDP1	TradeGate	EUR	Delayed

Add to/Remove from a Portfolio Add to Watchlist

18.35 +0.73 +4.15%

05:04:59 - Closed. Currency in EUR

Type: Equity

Market: Germany

ISIN: US04280A1007

S/N: A2AGYB

Volume: 2,415
Bid/Ask: 18.27 / 18.48
Day's Range: 17.51 - 18.50

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

Arrowhead Pharmaceuticals Inc Company Profile

Get an in-depth profile of Arrowhead Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

525

Equity Type

ORD

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company’s product pipeline includes Plozasiran, which has completed Phase 3 clinical trial to treat hypertriglyceridemia, dyslipidemia, and familial chylomicronemia syndrome; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; and Fazirsiran that is in Phase 3 clinical trial for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. It also develops Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; GSK-4532990 to treat metabolic-dysfunction associated steatohepatitis (MASH); and Daplusiran/Tomligisiran which is in Phase 2 clinical trial for the treatment of Chronic Hepatitis B. In addition, the company is developing ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with MASH; ARO-INHBE to reduce the hepatic expression of the INHBE gene and its secreted gene product; ARO-RAGE to treat inflammatory lung disease; ARO-MUC5AC to treat muco-obstructive pulmonary diseases; and ARO-MMP7 for the treatment of idiopathic pulmonary fibrosis that is in Phase 1/2a clinical trials. Further, it develops ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-DM1 to treat patient with Type 1 Myotonic Dystrophy; ARO-C3 to treat complement-mediated renal disease; ARO-CFB for the treatment of complement-mediated kidney disease that is in Phase 1/2a clinical trial; and ARO-ATXN2 for the treatment of Spinocerebellar Ataxia Type 2 that is in Phase 1 clinical trial. Arrowhead Pharmaceuticals, Inc. has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Horizon Therapeutics Ireland DAC; Takeda Pharmaceutical Company Limited; and with Amgen Inc. The company was founded in 2003 and is headquartered in Pasadena, California.

Contact Information

Address 177 East Colorado Boulevard Suite 700
Pasadena, 91105
United States

Phone 626 304 3400

Fax 626 304 3401

Web arrowheadpharma.com

Top Executives

Name	Age	Since	Title
Christopher R. Anzalone	56	2007	CEO, President & Director
Robert G. Gish	-	-	Chairman of Hepatitis B Clinical Advisory Board
Carlo Ferrari	-	-	Member of Hepatitis B Clinical Advisory Board
Johnson Y. N. Lau	-	-	Member of Hepatitis B Clinical Advisory Board
Hongbo Lu	53	2024	Independent Director
Douglas S. Ingram	62	2024	Director
Rohit Loomba	-	-	Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board
Michael S. Perry	66	2011	Independent Lead Director
William D. Waddill	68	2018	Independent Director
Jeffrey H. Teckman	-	-	Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board
Stephen Alister Locarnini	-	-	Member of Hepatitis B Clinical Advisory Board
Ching-Lung Lai	-	-	Member of Hepatitis B Clinical Advisory Board
Victoria M. Vakiener	61	2022	Independent Director
Mauro Ferrari	66	2008	Independent Director
Mark M. Davis	-	-	Founder and Founder & Director of Insert Therapeutics Inc & Calando
James K. Stoller	-	-	Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board
Adeoye Y. Olukotun	80	2020	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Philippines's comment guidelines and agree to the terms described.

I Agree

ARWR Comments

Write your thoughts about Arrowhead Pharmaceuticals Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d62-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d62-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d62-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

PSEi Composite	6,330.46	+30.79	+0.49%
Nikkei 225	38,667.00	+195.50	+0.51%
Shanghai	3,227.12	-13.82	-0.43%
US 500	5,954.1	+4.3	+0.07%
US Tech 100	21,249.3	+11.5	+0.05%
DAX	20,574.68	+303.35	+1.50%
Dollar Index	108.890	-0.060	-0.06%

Crude Oil WTI	79.14	+0.43	+0.55%
Brent Oil	82.47	+0.02	+0.02%
Natural Gas	4.106	-0.032	-0.77%
Gold	2,726.30	+8.50	+0.31%
Silver	31.615	+0.084	+0.27%
US Soybeans	1,037.88	-4.87	-0.47%
Copper	4.4120	+0.0140	+0.32%

Philippines 2Y	5.740	+0.046	+0.81%
Philippines 10Y	6.429	+0.051	+0.80%
Philippines 20Y	6.487	+0.062	+0.96%
U.S. 2Y	4.276	+0.012	+0.28%
U.S. 10Y	4.658	+0.005	+0.11%
U.S. 30Y	4.884	+0.006	+0.12%
Germany 10Y	2.5275	-0.0005	0.00%

Alphabet C	196.98	+5.93	+3.10%
Golden Haven	2,166.00	-82.00	-3.65%
Anheuser Busch ADR	46.46	-0.03	-0.06%
Booking	4,829.64	+50.83	+1.06%
Apple	237.87	+4.59	+1.97%
Alibaba ADR	82.44	+0.76	+0.93%
Tesla	428.22	+31.86	+8.04%

Recent Quotes

	Name	Price	Chg.	Chg. %
	HDP1	18.35	+0.73	+4.15%

Market Movers

Name	Last	Chg. %	Vol.
SM Prime	24.600	+3.36%	12.04M
Ayala Land	26.200	+2.75%	10.59M
BDO Unibank	143.80	-0.14%	2.16M
International Container	395.000	+1.49%	1.15M
Ayala	570.00	-1.64%	570.28K
Ayala Pref	579.50	+16.32%	374.88K
PLDT	1,310.00	+2.34%	169.12K

Name	Last	Chg. %	Vol.
Globe Telecom Pref	2,300.00	+355.00%	21.12K
Ayala Pref	579.50	+16.32%	374.88K
Filipino Fund	8.100	+15.71%	5.00K
Lepanto Consolidated	0.0700	+15.38%	240.00K
Concrete Aggregates	49.40	+14.75%	0.20K
Benguet B	4.580	+13.09%	59.00K
GMA Holdings	6.070	+11.38%	1.20K

Name	Last	Chg. %	Vol.
Del Monte Pacific Pref	3.900	-61.00%	0
LFM Properties	0.05	-16.67%	30.00K
Swift Foods	0.056	-16.39%	3.65M
Omico	0.1370	-13.16%	30.00K
Bright Kindle	1.360	-8.11%	81.00K
PAL	4.640	-7.20%	2.80K
Dito CME Holdings	1.8600	-7.00%	82.58M